HEALTHPOINT’s Research and Development Department is enthusiastic and focused on bringing novel biologics and pharmaceuticals to the wound care community. In 2006, HEALTHPOINT debuted its new 80,000-square-foot research facility in Fort Worth, Texas. This state-of-the-art laboratory facilitates research on a variety of wound healing projects organized around five main areas: Microbiology, Formulations/Biochemistry, Cell Biology, Preclinical Sciences, and Clinical Sciences.
Our Microbiology laboratories evaluate the effects of antimicrobial agents against major wound pathogens. These laboratories also develop models for biofilm infection of wounds to help us understand how this infection contributes to non-healing wounds and discover effective treatments.
This area is focused on the development and testing of topical drug and device formulations, such as creams, lotions, gels, ointments, solutions, and foams. Research endeavors evaluate physical and chemical stability and drug delivery of these formulations, as well as test in vitro drug release.
Our Cell Biology laboratories are responsible for the investigation of new, cell-based therapies that improve wound healing. Capabilities include the study of delayed healing due to host health (as in diabetes patients), mammalian cell culture, plant cell culture, microscopy, histology, and general biochemical and protein analysis.
Preclinical Sciences is responsible for the management of non-GLP and GLP toxicology and pharmacology activities.
Our Research and Development team has extensive experience in running clinical trials at all stages of development, from Phase I through Phase IV. Our clinical projects currently involve a wide range of biologics, pharmaceuticals, and advanced medical devices.